Ebola may be slowing, but like most viruses it can
Post# of 9122
Whats really good about this story is, because of the Ebola issue, NanoLogix was able to use the sanctioned FDA fast tract to move the N-Assay through patent process in a shorter time span. When the N-Assay Patent is finally issued, Nanologix may be in a position to join forces with some other company/companies, who have the facilities to test for multiple viruses. Not just the Ebola virus.
So, I agree with you Shabby, doors may be opened for Nanologix that weren't there before the Ebola issue.